BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 24.66 USD -0.52% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

BridgeBio Pharma Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BridgeBio Pharma Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
BridgeBio Pharma Inc
NASDAQ:BBIO
Total Other Income
$3m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.6B
CAGR 3-Years
12%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$302m
CAGR 3-Years
76%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$578m
CAGR 3-Years
81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$65.2m
CAGR 3-Years
N/A
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
$6m
CAGR 3-Years
-49%
CAGR 5-Years
-35%
CAGR 10-Years
8%

See Also

What is BridgeBio Pharma Inc's Total Other Income?
Total Other Income
3m USD

Based on the financial report for Sep 30, 2024, BridgeBio Pharma Inc's Total Other Income amounts to 3m USD.

What is BridgeBio Pharma Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-34%

Over the last year, the Total Other Income growth was -2%. The average annual Total Other Income growth rates for BridgeBio Pharma Inc have been -34% over the past three years .

Back to Top